| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2723555 | The American Journal of Medicine | 2011 | 7 Pages |
Abstract
Non-CDI antimicrobial therapy after an episode of CDI is common and is associated with a 3-fold increase in the odds of recurrent disease. The added risk associated with antimicrobial exposure (regardless of duration) should be considered if such therapy is contemplated.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dimitri M. MD, MS, William H. BA, Douglas D. PharmD, Michael A. PhD, Frank A. MD, James R. MD,